Insiders Updates Wells Fargo initates Pliant Therapeutics Inc (PLRX) stock to an Overweight In a filing, Pliant Therapeutics Inc revealed its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.44 million
Insiders Updates Examining the Potential Price Growth of Pliant Therapeutics Inc (PLRX) Pliant Therapeutics Inc’s filing revealed that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.44 million on
Insiders Updates The Potential Rise in the Price of Pliant Therapeutics Inc (PLRX) following insiders activity Pliant Therapeutics Inc’s recent filing unveils that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.44 million